Cardiovascular outcomes and subclinical atherosclerosis in metabolic-associated steatotic liver disease: long-term follow-up from a specialized outpatient cohort
In MASLD patients under optimized clinical treatment, the incidence of cardiovascular events was lower than predicted by the Framingham score, although subclinical atherosclerosis remained highly prevalent at the end of follow-up.
Authors
- Basilio de B Pereira
- Cristiane A. Villela-Nogueira
- Nathalie C. Leite
- Natalia B. Wajsbrot
- Emília M do Nascimento
- Claudia Maria Equi
- Gláucia Maria M. de Oliveira
- Breno C. Vieira
- Ana Carolina F. Cardoso
- Carlos Eduardo C. Marques
- Pedro Miguel M. Nogueira
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Naval Postgraduate School (US)
- Universidade do Estado do Rio de Janeiro (BR)
- Institute for Postgraduate Medical Education (CZ)
- Hospital Universitário Clementino Fraga Filho (BR)
- Fundação Técnico Educacional Souza Marques (BR)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1097/meg.0000000000003140
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00